Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects

Overview of attention for article published in Arthritis Research & Therapy, October 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 48 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHODS FOR SELECTING PATIENTS FOR TREATMENT WITH AN NGF ANTAGONIST

Application WO-2023212586-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.